Search - tctmd.com

Displaying 481 - 500 of 1289

Sort: Relevancy | Date

Presentation TVT 2023

Treatment of Aortic Regurgitation Using Commercial TAVR Systems: Case Examples With Balloon Expanding and Self-Expanding Valves

Presenter: Tarun Chakravarty

June 09, 2023

Presentation TVT 2023

The Growing Unmet Clinical Need for Alternatives to Surgery in Patients With Aortic Regurgitation

Presenter: Tsuyoshi Kaneko

June 09, 2023

Presentation TVT 2023

Surgical Updates: Surgical Aortic Valve Repair for AR

Presenter: Bo Yang

June 09, 2023

Presentation TVT 2023

Tricuspid Regurgitation Progression in Patients with Left-sided Valvular Heart Disease Correction

Presenter: Cheng Wang

June 08, 2023

Presentation TVT 2023

The Natural History of Tricuspid Regurgitation after Transcatheter Aortic Valve Implantation

Presenter: James Brown

June 08, 2023

Presentation TVT 2023

Aortic Regurgitation and Time to TAVR in Trifecta Versus Non-Trifecta Bioprosthetic Valves

Presenter: Amr Abbas

June 08, 2023

Presentation TVT 2023

Compassionate Use Experience with J-Valve for Native Aortic Regurgitation: First 30 Cases with a Dedicated Transfemoral System in North America

Presenter: Santiago Garcia

June 08, 2023

Presentation TVT 2023

SPOTLIGHT INNOVATION LECTURE: TAVR in Aortic Regurgitation: A Different Disease, A Different Valve!

Presenter: Raj Makkar

June 08, 2023

Presentation TVT 2023

Carillon Mitral Contour System® Case Experience

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

The Basis of Transcatheter Annular Restoration (TAR) for Ventricular Remodeling: A closer look at the mechanism of action

Presenter: Richard Cheng

June 08, 2023

Presentation TVT 2023

The European Experience – What we have learned

Presenter: Murat Yildiz

June 08, 2023

Presentation TVT 2023

Carillon Mitral Contour System® and the EMPOWER Trial – Overview and its Importance in interventional heart failure

Presenter: Rahul Sharma

June 08, 2023

Presentation TVT 2023

Contemporary, Core-Lab Assessed, Acute Clinical Outcomes from 2000+ Patients with Mitral Regurgitation Treated with the 3rd and 4th Generation MitraClip™ Systems: Results from the EXPANDed Post Approval Studies

Presenter: Matthew Price

June 08, 2023

Presentation THT 2023

High Surgical Risk Aortic Regurgitation: New TAVR Alternatives

Presenter: Torsten Vahl

March 22, 2023

Presentation THT 2023

Case Resolution

Presenter: Hannah Rosenblum

March 20, 2023

Presentation THT 2023

Do Tx or VAD

Presenter: Gabriel Sayer

March 20, 2023

Presentation THT 2023

Do a Mitraclip

Presenter: Mark Reisman

March 20, 2023

Presentation THT 2023

Case Presentation

Presenter: Hannah Rosenblum

March 20, 2023

Presentation THT 2023

Latest on Mitra/Tx/LVAD

Presenter: Jerry Estep

March 20, 2023

Presentation THT 2023

MitraClip for Secondary Mitral Regurgitation with LVEF < 20%

Presenter: Brian Whisenant

March 20, 2023

Advertisement

Treatment of Aortic Regurgitation Using Commercial TAVR Systems: Case Examples With Balloon Expanding and Self-Expanding Valves

The Growing Unmet Clinical Need for Alternatives to Surgery in Patients With Aortic Regurgitation

Surgical Updates: Surgical Aortic Valve Repair for AR

Tricuspid Regurgitation Progression in Patients with Left-sided Valvular Heart Disease Correction

The Natural History of Tricuspid Regurgitation after Transcatheter Aortic Valve Implantation

Aortic Regurgitation and Time to TAVR in Trifecta Versus Non-Trifecta Bioprosthetic Valves

Compassionate Use Experience with J-Valve for Native Aortic Regurgitation: First 30 Cases with a Dedicated Transfemoral System in North America

SPOTLIGHT INNOVATION LECTURE: TAVR in Aortic Regurgitation: A Different Disease, A Different Valve!

Carillon Mitral Contour System® Case Experience

The Basis of Transcatheter Annular Restoration (TAR) for Ventricular Remodeling: A closer look at the mechanism of action

The European Experience – What we have learned

Carillon Mitral Contour System® and the EMPOWER Trial – Overview and its Importance in interventional heart failure

Contemporary, Core-Lab Assessed, Acute Clinical Outcomes from 2000+ Patients with Mitral Regurgitation Treated with the 3rd and 4th Generation MitraClip™ Systems: Results from the EXPANDed Post Approval Studies

High Surgical Risk Aortic Regurgitation: New TAVR Alternatives

Case Resolution

Do Tx or VAD

Do a Mitraclip

Case Presentation

Latest on Mitra/Tx/LVAD

MitraClip for Secondary Mitral Regurgitation with LVEF < 20%

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content